The instruments most frequently used to measure QoL were: the European Organization for Research and Treatment of Cancer - EORTC QLQ-C30, with 11 39.2% papers and a specific module, EORTC module - BR23 for breast cancer was used in three studies 10.7% and the Functional Assessment of Cancer Therapy - Breast- FACT-B was used in two 7.1% studies; EORTC module- HN35 for head and neck cancer was used in one 3.5% study and EORTC module-CR38 for colorectal cancer was used in one study 3.5%.
Para medir la CV, los instrumentos más utilizados fueron: 11 39,2% EuropeanOrganization for Research and Treatment of Cancer- EORTC QLQ-C30 y módulos específicos, el EORTC module- BR23 para cáncer de mama fue utilizado en tres 10,7% y el Functional Assessment of Cancer Therapy- Breast- FACT-B en dos 7,1% artículos, el EORTC module- HN35 para cáncer de cabeza y cuello fue usado en un 3,5% artículo y el EORTC module-CR38 para cáncer colorrectal en uno 3,5%.
Para mensurar a QV, os instrumentos mais utilizados foram: 11 39,2% EuropeanOrganization for Research and Treatment of Cancer- EORTC QLQ-C30 e módulos específicos, o EORTC module- BR23 para câncer de mama foi utilizado em três 10,7% e o Functional Assessment of Cancer Therapy- Breast- FACT-B em dois 7,1% artigos, o EORTC module- HN35 para câncer de cabeça e pescoço foi usado em um 3,5% artigo e o EORTC module-CR38 para câncer colorretal em um 3,5%.